Advanced search
Start date
Betweenand

Rehabilitation technology for prevention of musculoskeletal and foot dysfunctions of people with Diabetes Mellitus: FootCAre (FoCa) prevention randomized controlled trial

Grant number: 19/02522-0
Support type:Scholarships in Brazil - Doctorate
Effective date (Start): November 01, 2019
Effective date (End): October 31, 2022
Field of knowledge:Health Sciences - Physiotherapy and Occupational Therapy
Principal Investigator:Isabel de Camargo Neves Sacco
Grantee:Jane Suelen Silva Pires Ferreira
Home Institution: Faculdade de Medicina (FM). Universidade de São Paulo (USP). São Paulo , SP, Brazil

Abstract

Considering the several alterations on the feet and ankles present in patients with Diabetic Polyneuropathy (DPN) and the need for self-care in order to avoid more serious complications such as ulcer and amputation, the inclusion of a protocol to strengthen the musculature of the feet, in which the patient can self-manage can be presented as an efficient method, since such exercises aim at specifically strengthening the PND compromised muscles. The project will be a health technology assessment to investigate the safety, effectiveness and adherence of the use of a rehabilitation technology (software sistema de orientação ao pé diabético that customizes a protocol of therapeutic exercises for the foot and ankle of individuals with diabetes) and the effects of the use of such technology on the clinical responses of DPN (tactile and vibration sensitivities, functional balance and foot functionality) and gait biomechanics. To access the effectiveness of the software, it will be designed a parallel controlled independent controlled preventive trial with random allocation and blinding of the evaluators for prevention and Foot Care (FOCA trial). The sample will be composed of 62 patients with DPN of up to 65 years who will be randomly divided into the control or intervention groups. The subjects will be assessed in 3 moments. The assessment includes gait kinematic and kinetics and plantar pressure distribution during gait, DPN symptoms, severity of neuropathy and foot muscle strength. The hypothesis of this study is that the intervention group will improve the neuropathic symptoms, reduce the severity of the neuropathy, improve sensitivity modalities, functional balance and functionality of the feet, when compared to the control group after 12 weeks of intervention, moreover, that adherence to the use of self-care tools will be equal to or greater than 80% and that the technology will represent greater viability with respect to quality of life. (AU)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SILVA, E. Q.; SUDA, E. Y.; SANTOS, D. P.; VERISSIMO, J. L.; FERREIRA, J. S. S. P.; CRUVINEL JUNIOR, R. H.; MONTEIRO, R. L.; SARTOR, C. D.; SACCO, I. C. N. Effect of an educational booklet for prevention and treatment of foot musculoskeletal dysfunctions in people with diabetic neuropathy: the FOotCAre (FOCA) trial II, a study protocol of a randomized controlled trial. Trials, v. 21, n. 1 FEB 13 2020. Web of Science Citations: 0.
FERREIRA, J. S. S. P.; CRUVINEL JUNIOR, R. H.; SILVA, E. Q.; VERISSIMO, J. L.; MONTEIRO, R. L.; PEREIRA, D. S.; SUDA, E. Y.; SARTOR, C. D.; SACCO, I. C. N. Study protocol for a randomized controlled trial on the effect of the Diabetic Foot Guidance System (SOPeD) for the prevention and treatment of foot musculoskeletal dysfunctions in people with diabetic neuropathy: the FOotCAre (FOCA) trial I. Trials, v. 21, n. 1 JAN 13 2020. Web of Science Citations: 0.
FERREIRA, JANE S. S. P.; PANIGHEL, JOAO P.; SILVA, ERICA Q.; MONTEIRO, RENAN L.; CRUVINEL JUNIOR, RONALDO H.; SACCO, ISABEL C. N. Foot function and strength of patients with diabetes grouped by ulcer risk classification (IWGDF). DIABETOLOGY & METABOLIC SYNDROME, v. 11, n. 1 OCT 30 2019. Web of Science Citations: 0.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.